Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
57-15-8
Name of the chemical
Chlorobutanol
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
General Information
Revision date
2015-11-10
Product name
Papaverine Hydrochloride Injection, USP
1.2.1 Relevant identified uses
Recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm,
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
Luitpold Pharmaceuticals, Inc
Section 2
Classification (GHS-US)
Not classified
2.2 Label elements
GHS-US Labeling No labeling applicable
Other hazards
Exposure to this product may result in excessive sedation, central nervous system depression, headache, malaise, skin rash, vomiting, weakness, anorexia, constipation or diarrhea. Increases in heart rate, blood pressure and depth of respiration may be noted. Refer to package insert for more information. 2.4.
Ingredient(s) with unknown acute toxicity
No data available
